| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.031 | 0.6 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.6 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |